Kindstar Globalgene Technology Inc
HKEX:9960
Intrinsic Value
Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. [ Read More ]
The intrinsic value of one Kindstar Globalgene Technology Inc stock under the Base Case scenario is hidden HKD. Compared to the current market price of 1.55 HKD, Kindstar Globalgene Technology Inc is hidden .
Valuation Backtest
Kindstar Globalgene Technology Inc
Run backtest to discover the historical profit from buying and selling Kindstar Globalgene Technology Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Kindstar Globalgene Technology Inc
Current Assets | 2.7B |
Cash & Short-Term Investments | 2B |
Receivables | 581.5m |
Other Current Assets | 101.8m |
Non-Current Assets | 960.6m |
Long-Term Investments | 296.4m |
PP&E | 478.3m |
Intangibles | 40.8m |
Other Non-Current Assets | 145.1m |
Current Liabilities | 743.8m |
Accounts Payable | 221.7m |
Accrued Liabilities | 277.1m |
Short-Term Debt | 152.9m |
Other Current Liabilities | 92m |
Non-Current Liabilities | 53.4m |
Long-Term Debt | 29.3m |
Other Non-Current Liabilities | 24.2m |
Earnings Waterfall
Kindstar Globalgene Technology Inc
Revenue
|
967.3m
CNY
|
Cost of Revenue
|
-517.2m
CNY
|
Gross Profit
|
450m
CNY
|
Operating Expenses
|
-518.1m
CNY
|
Operating Income
|
-68.1m
CNY
|
Other Expenses
|
109.4m
CNY
|
Net Income
|
41.3m
CNY
|
Free Cash Flow Analysis
Kindstar Globalgene Technology Inc
Profitability Score
Profitability Due Diligence
Kindstar Globalgene Technology Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Kindstar Globalgene Technology Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Kindstar Globalgene Technology Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Kindstar Globalgene Technology Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Kindstar Globalgene Technology Inc
According to Wall Street analysts, the average 1-year price target for Kindstar Globalgene Technology Inc is 3.22 HKD .
Shareholder Return
Price
Kindstar Globalgene Technology Inc
Average Annual Return | -43.97% |
Standard Deviation of Annual Returns | 16.19% |
Max Drawdown | -85% |
Market Capitalization | 1.4B HKD |
Shares Outstanding | 985 911 104 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. The company is headquartered in Wuhan, Hubei. The company went IPO on 2021-07-16. The firm operates nine segments. Hematology Testing segment includes testing services related to blood diseases. Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. Infectious Diseases segment includes testing services from the infection department. Oncology segment includes testing related to oncology diseases. Neurology segment includes testing services related to neurological diseases undertaken by the Group. Maternity-related Diseases segment includes testing services related to maternity. COVID-19 Related Testing segment includes testing services related to COVID-19. Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Others segment includes testing services for research and development (R&D) projects and others and miscellaneous services.
Contact
IPO
Employees
Officers
The intrinsic value of one Kindstar Globalgene Technology Inc stock under the Base Case scenario is hidden HKD.
Compared to the current market price of 1.55 HKD, Kindstar Globalgene Technology Inc is hidden .